Cite
HARVARD Citation
Steeland, S. et al. (2018). Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease. EMBO molecular medicine. 10 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Steeland, S. et al. (2018). Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease. EMBO molecular medicine. 10 (4), p. n/a. [Online].